Prescribe to Save Lives

Baystate Medical Center294 enrolled

Overview

The U.S. is in the midst of an epidemic of opioid overdose deaths. The common use of opioids among persons living with HIV, along with their common use of benzodiazepines, has resulted in high rates of opioid overdose among this population. This study will test the implementation of evidence-based training, mentoring, technical support, and academic detailing to encourage HIV physicians to adopt evidence-based interventions to reduce overdose risk and treat opioid addiction.

Study Type

INTERVENTIONAL

Allocation

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

294

Conditions

Opioid-Related Disorders Drug Overdose

Interventions

Implementation interventionBEHAVIORAL

The implementation intervention includes peer-to-peer training, post-training outreach, proactive expert support, and assistance with addressing environmental barriers.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: Clinicians and staff of HIV practice sites that: * Receive Ryan White Funding; * Treat adults with HIV; * Have 3 or more prescribing clinicians; * Have an electronic medical record (EMR) with an electronic medication list. Exclusion Criteria: * Sites located in states with fewer than 500 Persons Living With HIV (PLWH) will be excluded

Locations (2)

University of Massachusetts Medical School - Baystate

Springfield, Massachusetts, United States

The Miriam Hospital

Providence, Rhode Island, United States

Outcomes

Primary Outcomes

Change in naloxone prescribing behavior

Number of clinicians that prescribe naloxone. This information will be collected from electronic medical record (EMR) data.

Time frame: baseline to 6 months

Secondary Outcomes

Change in perception about pharmacotherapy for opioid use disorder; 6-month

Opinions About Medication Assisted Treatment (OAMAT) survey

Time frame: baseline to 6 months

Change in perception about pharmacotherapy for opioid use disorder; 12-month

Opinions About Medication Assisted Treatment (OAMAT) survey

Time frame: baseline to 12 months

Change in prescribing motivation; 6 months

Change in Motivation Scale

Time frame: baseline to 6 months

Change in prescribing motivation; 12 months

Change in Motivation Scale

Time frame: baseline to 12 months

Change in prescriber training

Number of prescribers that have completed buprenorphine training.

Time frame: baseline to 12 months

Change in buprenorphine prescribing behavior

Prevalence of buprenorphine prescription. This information will be collected from EMR data.

Time frame: baseline to 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.